Klinisk Biokemi i Norden Nr 4, vol. 28, 2016 - page 11

Early identification of clinically relevant bacterial infections is crucial to improving patient
outcomes. Furthermore, identifying patients that benefit from antibiotic treatment and monitoring
of antibiotic treatment is recommended for a patient centered therapy. The determination of the
infection and sepsis parameter
Procalcitonin (PCT)
with the immunoassay analyzer Samsung
LABGEO
IB10
allows now for
rapid and reliable decision making 24/7
in acute care settings.
For more information visit us at thermoscientific.com/brahms
NEW:
PCT testing
on Samsung
LABGEO
IB10
Samsung IB B·R·A·H·M·S PCT
at point of care
© 2016 Thermo Fisher Scientific Inc. All rights reserved. B·R·A·H·M·S PCT™ and all other
trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise
specified. Samsung LABGEO
®
is a registered trademark of Samsung C&T Corporation.
Thermo Fisher Scientific products are distributed worldwide; not all intended uses and
applications mentioned in this printing are registered in every country.
Smart
infection diagnosis
Contact
Petra Östlund |
| + 46 (0)8 594 691 30
1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18,19,20,21,...48
Powered by FlippingBook